Signet Investment Advisory Group Inc. Has $3.23 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Signet Investment Advisory Group Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 7.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,342 shares of the healthcare conglomerate’s stock after acquiring an additional 416 shares during the period. UnitedHealth Group accounts for approximately 1.7% of Signet Investment Advisory Group Inc.’s holdings, making the stock its 21st largest position. Signet Investment Advisory Group Inc.’s holdings in UnitedHealth Group were worth $3,230,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Delos Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the period. True Wealth Design LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at $31,000. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at $31,000. Signature Resources Capital Management LLC raised its stake in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the last quarter. Finally, Red Tortoise LLC raised its stake in UnitedHealth Group by 45.1% during the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 23 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 0.3 %

Shares of UNH stock traded down $1.93 during trading hours on Friday, hitting $577.68. 2,728,939 shares of the company were exchanged, compared to its average volume of 4,224,914. The firm has a market cap of $533.44 billion, a P/E ratio of 35.31, a P/E/G ratio of 1.61 and a beta of 0.59. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $591.54. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.85 and a current ratio of 0.88. The company has a 50 day simple moving average of $529.38 and a two-hundred day simple moving average of $507.45.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period last year, the business earned $6.14 EPS. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on UNH. Barclays increased their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, August 13th. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Finally, Argus increased their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.